Emergence of Clostridium difficile NAP1 in Latin America

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 669-670

  Quesada Gómez, Carlos ^a   Rodríguez, César ^a   Gamboa Coronado, María Del Mar ^a   Rodríguez Cavallini, Evelyn ^a   Du, Tim ^b   Mulvey, Michael R ^b   Villalobos Zúñiga, Manuel ^c   Boza Cordero, Ricardo ^c  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c HOSPITAL SAN JUAN DE DIOS   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE; GENOTYPE; LETTER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTH AND CENTRAL AMERICA;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLUSTER ANALYSIS; COSTA RICA; CROSS INFECTION; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY;

CLOSTRIDIUM DIFFICILE;

EID: 75649128744     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02196-09     Document Type: Letter

References (10)

1. Alfa, M. J., A. Kabani, D. Lyerly, S. Moncrief, L. M. Neville, A. Al-Barrak, G. K. H Harding, B. Dyck, K. Olekson, and J. M. Embil. 2000. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 38:2706-2714.
2. Clinical and Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. CLSI document M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Kato, N., C.-Y. Ou, H. Kato, S. L. Bartley, V. K. Brown, V. R. Dowell, and L. Ueno. 1991. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J. Clin. Microbiol. 29:33-37.
4. McDonald, L. C., G. E. Killgore, A. Thompson, R. C. Owens, S. V. Kazakova, S. P. Sambol, S. Johnson, and D. N. Gerding. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
5. Musher, D. M., N. Logan, V. Mehendiratta, R. E. Polk, M. Oinonen, A. Pakyz, M. H. Wilcox, J. Freeman, K. Iwata, A. Doi, N. Furuya, L. C. McDonald, D. N. Gerding, V. G. Loo, M. D. Libman, and A. Dascal. 2006. Epidemic Clostridium difficile. N. Engl. J. Med. 354:1199-1203.
6. Peláez, T., L. Alcalá, R. Alonso, M. Rodríguez-Créixems, J. M. García-Lechuz, and E. Bouza. 2002. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob. Agents Chemother. 46:1647-1650.
7. Razavi, B., A. Apisarnthanarak, and L. M. Mundy. 2007. Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance. Infection 35: 300-307.
8. Rodríguez-Palacios, A., R. J. Reid-Smith, H. R. Staempfli, D. Daignault, N. Janecko, B. P. Avery, H. Martin, A. D. Thompson, L. C. McDonald, B. Limbago, and J. S. Weese. 2009. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg. Infect. Dis. 15:802-805.
9. Spigaglia, P., and P. Mastrantonio. 2004. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J. Med. Microbiol. 53:1129-1136.
10. Stubbs, S., M. Rupnik, M. Gibert, J. Brazier, B. Duerden, and M. Popoff. 2000. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol. Lett. 186:307-312.